Suppr超能文献

卡塔尔国针对门诊血液透析服务中新冠病毒奥密克戎变异株危机的国家应对措施。

National response to the COVID-19 Omicron variant crisis in the ambulatory hemodialysis service in the State of Qatar.

作者信息

Hamad Abdullah I, Asim Muhammad, Othman Muftah A, Abuhelaiqa Essa A, Shurrab Alaedine, Elmadhoun Ihab T, Ali Al-Malki Hassan, Alkadi Mohamad M

机构信息

Division of Nephrology, Department of Medicine, Hamad General Hospital, Doha, Qatar E-mail:

Division of Nephrology, Department of Medicine, Hazm Mebaireek General Hospital, Doha, Qatar.

出版信息

Qatar Med J. 2022 Aug 23;2022(3):38. doi: 10.5339/qmj.2022.38. eCollection 2022.

Abstract

The coronavirus disease (COVID-19) pandemic has had a significant worldwide impact since its emergence in 2019. End-stage kidney disease patients have been among the most vulnerable population affected and have a higher risk of acquiring infection and developing more severe disease. We have encountered three major COVID-19 waves in Qatar and they have required different strategies to overcome. The most recent wave was due to the Omicron variant characterized by higher transmissibility. The monthly incidence of COVID-19 infection during the Omicron wave in patients with end-stage renal disease peaked at 256 patients compared to 35 and 39 patients during the first and second waves, respectively. In addition, more than one-third of our dialysis staff became infected during this wave. Unlike the previous two waves, COVID-19 due to the Omicron variant was less severe with only 5% of hemodialysis patients requiring admission to the intensive care unit compared to 25% during the previous waves. The Omicron variant wave resulted in a crisis in our country due to the high number of non-hospitalized COVID-19 hemodialysis patients and the severe staff shortage. Several measures were taken to overcome the crisis, such as designating one facility to dialyze all COVID-19 ambulatory patients, reducing dialysis sessions to 3 hours, and introducing a fourth dialysis shift. This article describes the challenges we faced in the ambulatory hemodialysis service during the Omicron wave and the measures taken in the COVID-19 and non-COVID-19 designated facilities to combat the crisis.

摘要

自2019年出现以来,冠状病毒病(COVID-19)大流行在全球范围内产生了重大影响。终末期肾病患者一直是受影响最脆弱的人群之一,感染风险更高,病情也更严重。在卡塔尔,我们经历了三次主要的COVID-19浪潮,每次都需要采取不同的策略来应对。最近一波是由传播性更强的奥密克戎变种引起的。在奥密克戎浪潮期间,终末期肾病患者中COVID-19感染的月发病率峰值为256例,而第一波和第二波期间分别为35例和39例。此外,在这一波疫情中,我们超过三分之一的透析工作人员被感染。与前两波不同,由奥密克戎变种引起的COVID-19病情较轻,只有5%的血液透析患者需要入住重症监护病房,而前两波这一比例为25%。由于大量未住院的COVID-19血液透析患者以及严重的人员短缺,奥密克戎变种浪潮在我国引发了一场危机。我们采取了多项措施来克服这场危机,比如指定一家机构为所有COVID-19门诊患者进行透析、将透析疗程减至3小时以及增加第四班透析。本文描述了在奥密克戎浪潮期间我们在门诊血液透析服务中面临的挑战,以及在COVID-19指定设施和非COVID-19指定设施中为应对危机所采取的措施。

相似文献

1
National response to the COVID-19 Omicron variant crisis in the ambulatory hemodialysis service in the State of Qatar.
Qatar Med J. 2022 Aug 23;2022(3):38. doi: 10.5339/qmj.2022.38. eCollection 2022.
6
Algeria's preparedness for Omicron variant and for the fourth wave of COVID-19.
Glob Health Med. 2021 Dec 31;3(6):413-414. doi: 10.35772/ghm.2021.01117.
7
8
Mortality and associated risk factors of COVID-19 infection in dialysis patients in Qatar: A nationwide cohort study.
PLoS One. 2021 Jul 22;16(7):e0254246. doi: 10.1371/journal.pone.0254246. eCollection 2021.

引用本文的文献

1
Severe acute respiratory infections: An epidemiological analysis of surveillance data in Bahrain, 2018-2022.
Qatar Med J. 2024 Jul 1;2024(3):28. doi: 10.5339/qmj.2024.28. eCollection 2024.
2
COVID-19 and patients on renal replacement therapy: Perspective from the State of Qatar.
Qatar Med J. 2024 May 9;2024(1):1. doi: 10.5339/qmj.2024.1. eCollection 2024.
3
Cardiovascular calcification in hemodialysis patients: A Qatar-based prevalence and risk factors study.
Qatar Med J. 2024 Mar 14;2024(1):18. doi: 10.5339/qmj.2024.18. eCollection 2024.
4
Determinants of vaccine adherence among non-dialysis chronic kidney disease patients in Qatar.
Qatar Med J. 2024 Jan 6;2023(4):33. doi: 10.5339/qmj.2023.33. eCollection 2023.
6
From past to present: Exploring COVID-19 in Qatar's hemodialysis population across Omicron dominant and pre-Omicron periods.
PLoS One. 2023 Sep 14;18(9):e0291266. doi: 10.1371/journal.pone.0291266. eCollection 2023.
7
Time-Series Forecasting of Hemodialysis Population in the State of Qatar by 2030.
Qatar Med J. 2023 Feb 20;2023(1):6. doi: 10.5339/qmj.2023.6. eCollection 2023.

本文引用的文献

1
What the Omicron wave is revealing about human immunity.
Nature. 2022 Feb;602(7895):22-25. doi: 10.1038/d41586-022-00214-3.
2
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.
Nature. 2022 Mar;603(7902):679-686. doi: 10.1038/s41586-022-04411-y. Epub 2022 Jan 7.
3
The emergence of new SARS-CoV-2 variant (Omicron) and increasing calls for COVID-19 vaccine boosters-The debate continues.
Travel Med Infect Dis. 2022 Jan-Feb;45:102246. doi: 10.1016/j.tmaid.2021.102246. Epub 2021 Dec 21.
4
COVID-19 Risk Factors and Mortality Outcomes Among Medicare Patients Receiving Long-term Dialysis.
JAMA Netw Open. 2021 Nov 1;4(11):e2135379. doi: 10.1001/jamanetworkopen.2021.35379.
5
Mortality and associated risk factors of COVID-19 infection in dialysis patients in Qatar: A nationwide cohort study.
PLoS One. 2021 Jul 22;16(7):e0254246. doi: 10.1371/journal.pone.0254246. eCollection 2021.
7
COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider.
Am J Kidney Dis. 2021 May;77(5):748-756.e1. doi: 10.1053/j.ajkd.2021.01.003. Epub 2021 Jan 17.
9
Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients.
Kidney Int. 2020 Dec;98(6):1519-1529. doi: 10.1016/j.kint.2020.07.042. Epub 2020 Aug 25.
10
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19.
Kidney Int. 2020 Dec;98(6):1530-1539. doi: 10.1016/j.kint.2020.07.030. Epub 2020 Aug 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验